Fornix Biosciences (FORBI) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Fornix Biosciences Company Snapshot

Business Description:

Fornix Biosciences operates in the Pharmaceutical preparations sector. Fornix Biosciences NV is a Netherlands-based company that focuses on the research and development, production, marketing and sale related to diagnostic and therapeutic allergen products and medical aids, and the marketing, sale and distribution of medical aids and medical and nursing disposables. The activities are organized into two divisions, which operate via separate operating companies; the Allergy Division and the Medical Aids Division. The Allergy Division is engaged in the marketing, sale and distribution of medical aids and immunotherapeutic allergen products in Germany. The Division Medical Aids is focused on the marketing, sale and distribution of medical aids and medical and nursing disposables. In our complete report available for purchase the company is compared to: Bavarian Nordic AS, MediGene AG and Origio A/S.

Stock Performance Chart for Fornix Biosciences

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .62
(Figures in Euro)

1 Week	-0.6%	13 Weeks	-5.8%

4 Weeks	5.3%	52 Weeks	-75.3%

Fornix Biosciences Key Data:

Ticker:	FORBI	Country:	NETHERLANDS

Exchanges:	AMS	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2009 Sales	37,756,000 (Year Ending Jan 2010).	Employees:	2

Currency:	Euro	Market Cap:	4,801,378

Fiscal Yr Ends:	December	Shares Outstanding:	7,731,688

Share Type:	Certicaten	Closely Held Shares:	7,587,801

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.